From the Symposium Co-Chairs

Dear Colleagues,

Here are four great reasons you should attend this exciting symposium:

1. This symposium brings together many experts who are actively using stem cells and primary cells in screening, target identification and validation, ADMET applications, tissue engineering and cellular therapy.
   
   
2. If you are in drug discovery, either as a biologist, biochemist, pharmacologist or medicinal chemist, you need to understand the tremendous opportunity to use physiologically relevant cells and cell lines in your discovery projects.
   
   
3. As more and more labs begin to employ cell-based assays and high-content screening to discover pathway specific drug leads, it is important that drug targets are interrogated in cellular backgrounds with appropriate signaling pathways are conserved.
   
   
4. Come and hear from these experts who are pioneering this effort and make a quantum leap in your drug discovery thinking!

Sincerely,

Chair Maria Webb, Ph.D. VP Pre-Clinical Research Biology and Pharmacology Pharmacopeia, USA

Co-Chair Sitta Sittampalam, Ph.D. Department of Pharmacology, Toxicology & Therapeutics, Deputy Director Office Therapeutics & Drug Discovery, Kansas Masonic Cancer Research Center, The University of Kansas Medical Center